Aurinia Pharmaceuticals (AUPH) Earnings Date & Reports

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUPH is expected to report earnings to fall 15.00% to 23 cents per share on October 29

Aurinia Pharmaceuticals AUPH Stock Earnings Reports

Q3'26

Est.

$0.24

Q2'26

Beat

by $0.05

Q1'26

Beat

by $0.06

Q4'25

Beat

by $1.38

Q3'25

Beat

by $0.07

The last earnings report on August 06 showed earnings per share of 28 cents, beating the estimate of 23 cents. With 700.77K shares outstanding, the current market capitalization sits at 2.22B.

View a ticker or compare two or three

AUPH

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days